Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice

Cell Host and Microbe

Volumn 12, Issue 2, 2012, Pages 139-152

  Carvalho, Frederic A ^a,b,c   Koren, Omry ^d   Goodrich, Julia K ^d   Johansson, Malin E V ^e   Nalbantoglu, Ilke ^f   Aitken, Jesse D ^a   Su, Yueju ^a   Chassaing, Benoit ^a   Walters, William A ^g   González, Antonio ^h   Clemente, Jose C ⁱ   Cullender, Tyler C ^d   Barnich, Nicolas ^b   Darfeuille Michaud, Arlette ^b   Vijay Kumar, Matam ^a   Knight, Rob ⁱ   Ley, Ruth E ^d   Gewirtz, Andrew T ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c U1107 ^*  (France)

^d Department of Obstetrics Gynecology   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^h UCB 450   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; COLITIS; CONTROLLED STUDY; CROHN DISEASE; ESCHERICHIA COLI; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEOBACTERIA; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; COLITIS; ENTEROBACTERIACEAE; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; METAGENOME; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEOBACTERIA; TOLL-LIKE RECEPTOR 5;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; MUS; PROTEOBACTERIA;

EID: 84865134857     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2012.07.004     Document Type: Article

References (38)

1. L.C. Antunes, and B.B. Finlay A comparative analysis of the effect of antibiotic treatment and enteric infection on intestinal homeostasis Gut Microbes 2 2011 105 108
2. N. Barnich, J. Boudeau, L. Claret, and A. Darfeuille-Michaud Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease Mol. Microbiol. 48 2003 781 794 (Pubitemid 36819062)
3. M. Barthel, S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. Russmann, and W.D. Hardt Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host Infect. Immun. 71 2003 2839 2858 (Pubitemid 36519898)
4. F.A. Carvalho, N. Barnich, P. Sauvanet, C. Darcha, A. Gelot, and A. Darfeuille-Michaud Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin Inflamm. Bowel Dis. 14 2008 1051 1060
5. F.A. Carvalho, N. Barnich, A. Sivignon, C. Darcha, C.H. Chan, C.P. Stanners, and A. Darfeuille-Michaud Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM J. Exp. Med. 206 2009 2179 2189
6. F.A. Carvalho, J.D. Aitken, A.T. Gewirtz, and M. Vijay-Kumar TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage Mucosal Immunol. 4 2011 102 111
7. F.A. Carvalho, I. Nalbantoglu, S. Ortega-Fernandez, J.D. Aitken, Y. Su, O. Koren, W.A. Walters, R. Knight, R.E. Ley, and M. Vijay-Kumar Interleukin-1beta (IL-1beta) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis Gut 61 2012 373 384
8. F.E. Castaneda, B. Walia, M. Vijay-Kumar, N.R. Patel, S. Roser, V.L. Kolachala, M. Rojas, L. Wang, G. Oprea, and P. Garg Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP Gastroenterology 129 2005 1991 2008 (Pubitemid 41772976)
9. J.H. Cho, and S.R. Brant Recent insights into the genetics of inflammatory bowel disease Gastroenterology 140 2011 1704 1712
10. A. Darfeuille-Michaud Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease Int. J. Med. Microbiol. 292 2002 185 193
11. A. Darfeuille-Michaud, C. Neut, N. Barnich, E. Lederman, P. Di Martino, P. Desreumaux, L. Gambiez, B. Joly, A. Cortot, and J.F. Colombel Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease Gastroenterology 115 1998 1405 1413 (Pubitemid 28545991)
12. M. Derrien, M.W. van Passel, J.H. van de Bovenkamp, R.G. Schipper, W.M. de Vos, and J. Dekker Mucin-bacterial interactions in the human oral cavity and digestive tract Gut Microbes 1 2010 254 268
13. A.W. Dupont, and H.L. Dupont The intestinal microbiota and chronic disorders of the gut Nat. Rev. Gastroenterol. Hepatol. 8 2011 523 531
14. M.L. Gilmor, N.R. Nash, A. Roghani, R.H. Edwards, H. Yi, S.M. Hersch, and A.I. Levey Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles J. Neurosci. 16 1996 2179 2190 (Pubitemid 26154330)
15. J.P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J.P. Cezard, J. Belaiche, S. Almer, C. Tysk, C.A. O'Morain, and M. Gassull Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603 (Pubitemid 32531408)
16. M.E. Johansson, M. Phillipson, J. Petersson, A. Velcich, L. Holm, and G.C. Hansson The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria Proc. Natl. Acad. Sci. USA 105 2008 15064 15069
17. N. Kamada, Y.G. Kim, H.P. Sham, B.A. Vallance, J.L. Puente, E.C. Martens, and G. Nunez Regulated virulence controls the ability of a pathogen to compete with the gut microbiota Science 336 2012 1325 1329
18. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu. Rev. Immunol. 28 2010 573 621
19. K.S. Kobayashi, M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nunez, and R.A. Flavell Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract Science 307 2005 731 734 (Pubitemid 40194644)
20. C. Lozupone, and R. Knight UniFrac: a new phylogenetic method for comparing microbial communities Appl. Environ. Microbiol. 71 2005 8228 8235 (Pubitemid 41803949)
21. C. Lupp, M.L. Robertson, M.E. Wickham, I. Sekirov, O.L. Champion, E.C. Gaynor, and B.B. Finlay Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae Cell Host Microbe 2 2007 204 (Pubitemid 47355207)
22. K.S. Matharu, E. Mizoguchi, C.A. Cotoner, D.D. Nguyen, B. Mingle, O.I. Iweala, M.E. McBee, A.T. Stefka, G. Prioult, and K.M. Haigis Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice Gastroenterology 137 2009 1380 1390
23. S. Mondot, F. Barreau, Z. Al Nabhani, M. Dussaillant, K. Le Roux, J. Dore, M. Leclerc, J.P. Hugot, and P. Lepage Altered gut microbiota composition in immune-impaired Nod2-/- mice Gut 61 2011 634 635
24. N.A. Nagalingam, J.Y. Kao, and V.B. Young Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis Inflamm. Bowel Dis. 17 2011 917 926
25. A. Nenci, C. Becker, A. Wullaert, R. Gareus, G. van Loo, S. Danese, M. Huth, A. Nikolaev, C. Neufert, and B. Madison Epithelial NEMO links innate immunity to chronic intestinal inflammation Nature 446 2007 557 561 (Pubitemid 46514732)
26. Y. Ogura, D.K. Bonen, N. Inohara, D.L. Nicolae, F.F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, and R.H. Duerr A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 2001 603 606 (Pubitemid 32531409)
27. C. Onyeagocha, M.S. Hossain, A. Kumar, R.M. Jones, J. Roback, and A.T. Gewirtz Latent cytomegalovirus infection exacerbates experimental colitis Am. J. Pathol. 175 2009 2034 2042
28. A. Rehman, C. Sina, O. Gavrilova, R. Hasler, S. Ott, J.F. Baines, S. Schreiber, and P. Rosenstiel Nod2 is essential for temporal development of intestinal microbial communities Gut 60 2011 1354 1362
29. J.D. Rioux, R.J. Xavier, K.D. Taylor, M.S. Silverberg, P. Goyette, A. Huett, T. Green, P. Kuballa, M.M. Barmada, and L.W. Datta Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis Nat. Genet. 39 2007 596 604 (Pubitemid 46676115)
30. N. Rolhion, F.A. Carvalho, and A. Darfeuille-Michaud OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82 Mol. Microbiol. 63 2007 1684 1700 (Pubitemid 46426710)
31. R.K. Sellon, S. Tonkonogy, M. Schultz, L.A. Dieleman, W. Grenther, E. Balish, D.M. Rennick, and R.B. Sartor Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice Infect. Immun. 66 1998 5224 5231 (Pubitemid 29044613)
32. M. Vijay-Kumar, C.J. Sanders, R.T. Taylor, A. Kumar, J.D. Aitken, S.V. Sitaraman, A.S. Neish, S. Uematsu, S. Akira, and I.R. Williams Deletion of TLR5 results in spontaneous colitis in mice J. Clin. Invest. 117 2007 3909 3921 (Pubitemid 350224100)
33. M. Vijay-Kumar, J.D. Aitken, A. Kumar, A.S. Neish, S. Uematsu, S. Akira, and A.T. Gewirtz Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced typhoid-like disease Infect. Immun. 76 2008 1276 1281 (Pubitemid 351428091)
34. M. Vijay-Kumar, J.D. Aitken, F.A. Carvalho, T.C. Cullender, S. Mwangi, S. Srinivasan, S.V. Sitaraman, R. Knight, R.E. Ley, and A.T. Gewirtz Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 Science 328 2010 228 231
35. A.W. Walker, J. Ince, S.H. Duncan, L.M. Webster, G. Holtrop, X. Ze, D. Brown, M.D. Stares, P. Scott, and A. Bergerat Dominant and diet-responsive groups of bacteria within the human colonic microbiota ISME J. 5 2011 220 230
36. A.W. Walker, J.D. Sanderson, C. Churcher, G.C. Parkes, B.N. Hudspith, N. Rayment, J. Brostoff, J. Parkhill, G. Dougan, and L. Petrovska High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease BMC Microbiol. 11 2011 7
37. B.P. Willing, J. Dicksved, J. Halfvarson, A.F. Andersson, M. Lucio, Z. Zheng, G. Jarnerot, C. Tysk, J.K. Jansson, and L. Engstrand A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes Gastroenterology 139 2010 1844 1854
38. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434 (Pubitemid 47123518)